FDAnews
www.fdanews.com/articles/186440-livanova-receives-ce-mark-for-nerve-stimulation-device

LivaNova Receives CE Mark for Nerve Stimulation Device

April 17, 2018

LivaNova received a CE Mark for its Vagus Nerve Stimulation Therapy system SenTiva generator for treating drug-resistant epilepsy.

The implantable device can detect seizures and automatically deliver an extra dose of therapy. The generator is also designed to log events including a patient’s body position and heart rate fluctuations. The system includes a tablet and a wireless programming wand to deliver personalized treatment.

The product received FDA clearance in October 2017.

View today's stories